Terms: = Germ cell tumor AND NT5C2, ENSG00000076685, 22978, P49902, PNT5, NT5B, GMP, cN-II
121 results:
1. Fully closed and automated enrichment of primary blood dendritic cells for cancer immunotherapy.
Schreibelt G; Duiveman-de Boer T; Pots JM; van Oorschot TGM; de Boer AJ; Scharenborg NM; van de Rakt MWMM; Bos K; de Goede AL; Petry K; Brüning M; Angerer C; Schöggl C; Dzionek A; de Vries IJM
Methods Cell Biol; 2024; 183():33-50. PubMed ID: 38548417
[TBL] [Abstract] [Full Text] [Related]
2. Generation and quality control of mature monocyte-derived dendritic cells for immunotherapy.
Datsi A; Falkowski L; Sorg RV
Methods Cell Biol; 2024; 183():1-31. PubMed ID: 38548408
[TBL] [Abstract] [Full Text] [Related]
3. Directing the migration of serum-free,
Parwani KK; Branella GM; Burnham RE; Burnham AJ; Bustamante AYS; Foppiani EM; Knight KA; Petrich BG; Horwitz EM; Doering CB; Spencer HT
Front Immunol; 2024; 15():1331322. PubMed ID: 38487542
[TBL] [Abstract] [Full Text] [Related]
4. Neuroblastoma: an ongoing cold front for cancer immunotherapy.
Kennedy PT; Zannoupa D; Son MH; Dahal LN; Woolley JF
J Immunother Cancer; 2023 Nov; 11(11):. PubMed ID: 37993280
[TBL] [Abstract] [Full Text] [Related]
5. PhotoPyro-Induced cGAS-STING Pathway Activation Enhanced Anti-Melanoma Immunotherapy via a Manganese-Coordinated Nanomedicine.
Feng Y; Wang G; Li W; Yan J; Yu X; Tian H; Li B; Dai Y
Adv Healthc Mater; 2024 Mar; 13(6):e2302811. PubMed ID: 37909376
[TBL] [Abstract] [Full Text] [Related]
6. Inhibition of tumor intrinsic BANF1 activates antitumor immune responses via cGAS-STING and enhances the efficacy of PD-1 blockade.
Wang M; Huang Y; Chen M; Wang W; Wu F; Zhong T; Chen X; Wang F; Li Y; Yu J; Wu M; Chen D
J Immunother Cancer; 2023 Aug; 11(8):. PubMed ID: 37620043
[TBL] [Abstract] [Full Text] [Related]
7. USP18 enhances the resistance of BRAF-mutated melanoma cells to vemurafenib by stabilizing cGAS expression to induce cell autophagy.
Ma ZR; Xiong QW; Cai SZ; Ding LT; Yin CH; Xia HL; Liu W; Dai S; Zhang Y; Zhu ZH; Huang ZJ; Wang Q; Yan XM
Int Immunopharmacol; 2023 Sep; 122():110617. PubMed ID: 37478666
[TBL] [Abstract] [Full Text] [Related]
8. Manganese facilitated cGAS-STING-IFNI pathway activation induced by ionizing radiation in glioma cells.
He Y; Yang Y; Huang W; Yang S; Xue X; Zhu K; Tan H; Sun T; Yang W
Int J Radiat Biol; 2023; 99(12):1890-1907. PubMed ID: 37406172
[TBL] [Abstract] [Full Text] [Related]
9. Mitochondria Transfer from Mesenchymal Stem cells Confers Chemoresistance to Glioblastoma Stem cells through Metabolic Rewiring.
Nakhle J; Khattar K; Özkan T; Boughlita A; Abba Moussa D; Darlix A; Lorcy F; Rigau V; Bauchet L; Gerbal-Chaloin S; Daujat-Chavanieu M; Bellvert F; Turchi L; Virolle T; Hugnot JP; Buisine N; Galloni M; Dardalhon V; Rodriguez AM; Vignais ML
Cancer Res Commun; 2023 Jun; 3(6):1041-1056. PubMed ID: 37377608
[TBL] [Abstract] [Full Text] [Related]
10. A Therapeutic Vaccine in Combination with Cyclic gmp-AMP Cures More Differentiated Melanomas in Mice.
Alam MM; Gower T; Jiang M; Oppenheim JJ; Yang D
J Immunol; 2023 May; 210(9):1428-1436. PubMed ID: 36947147
[TBL] [Abstract] [Full Text] [Related]
11. Photothermal-triggered dendrimer nanovaccines boost systemic antitumor immunity.
Shen S; Gao Y; Ouyang Z; Jia B; Shen M; Shi X
J Control Release; 2023 Mar; 355():171-183. PubMed ID: 36736909
[TBL] [Abstract] [Full Text] [Related]
12. DNA damage repair kinase DNA-PK and cGAS synergize to induce cancer-related inflammation in glioblastoma.
Taffoni C; Marines J; Chamma H; Guha S; Saccas M; Bouzid A; Valadao AC; Maghe C; Jardine J; Park MK; Polak K; De Martino M; Vanpouille-Box C; Del Rio M; Gongora C; Gavard J; Bidère N; Song MS; Pineau D; Hugnot JP; Kissa K; Fontenille L; Blanchet FP; Vila IK; Laguette N
EMBO J; 2023 Apr; 42(7):e111961. PubMed ID: 36574362
[TBL] [Abstract] [Full Text] [Related]
13. H3.3-G34 mutations impair DNA repair and promote cGAS/STING-mediated immune responses in pediatric high-grade glioma models.
Haase S; Banerjee K; Mujeeb AA; Hartlage CS; Núñez FM; Núñez FJ; Alghamri MS; Kadiyala P; Carney S; Barissi MN; Taher AW; Brumley EK; Thompson S; Dreyer JT; Alindogan CT; Garcia-Fabiani MB; Comba A; Venneti S; Ravikumar V; Koschmann C; Carcaboso ÁM; Vinci M; Rao A; Yu JS; Lowenstein PR; Castro MG
J Clin Invest; 2022 Nov; 132(22):. PubMed ID: 36125896
[TBL] [Abstract] [Full Text] [Related]
14. Phase I study of adjuvant immunotherapy with autologous tumor-infiltrating lymphocytes in locally advanced cervical cancer.
Huang H; Nie CP; Liu XF; Song B; Yue JH; Xu JX; He J; Li K; Feng YL; Wan T; Zheng M; Zhang YN; Ye WJ; Li JD; Li YF; Li JY; Cao XP; Liu ZM; Zhang XS; Liu Q; Zhang X; Liu JH; Li J
J Clin Invest; 2022 Aug; 132(15):. PubMed ID: 35727633
[TBL] [Abstract] [Full Text] [Related]
15. Lower Expression of GBP2 Associated With Less Immune cell Infiltration and Poor Prognosis in Skin Cutaneous Melanoma (SKCM).
Zhang S; Chen K; Zhao Z; Zhang X; Xu L; Liu T; Yu S
J Immunother; 2022 Jul-Aug 01; 45(6):274-283. PubMed ID: 35543550
[TBL] [Abstract] [Full Text] [Related]
16. tumor Treating Fields dually activate STING and AIM2 inflammasomes to induce adjuvant immunity in glioblastoma.
Chen D; Le SB; Hutchinson TE; Calinescu AA; Sebastian M; Jin D; Liu T; Ghiaseddin A; Rahman M; Tran DD
J Clin Invest; 2022 Apr; 132(8):. PubMed ID: 35199647
[TBL] [Abstract] [Full Text] [Related]
17. EZH2-CCF-cGAS Axis Promotes Breast Cancer Metastasis.
Duan D; Shang M; Han Y; Liu J; Liu J; Kong SH; Hou J; Huang B; Lu J; Zhang Y
Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163710
[TBL] [Abstract] [Full Text] [Related]
18. Phosphorylation of guanosine monophosphate reductase triggers a GTP-dependent switch from pro- to anti-oncogenic function of EPHA4.
Wolff DW; Deng Z; Bianchi-Smiraglia A; Foley CE; Han Z; Wang X; Shen S; Rosenberg MM; Moparthy S; Yun DH; Chen J; Baker BK; Roll MV; Magiera AJ; Li J; Hurley E; Feltri ML; Cox AO; Lee J; Furdui CM; Liu L; Bshara W; LaConte LEW; Kandel ES; Pasquale EB; Qu J; Hedstrom L; Nikiforov MA
Cell Chem Biol; 2022 Jun; 29(6):970-984.e6. PubMed ID: 35148834
[TBL] [Abstract] [Full Text] [Related]
19. Rationally designed drug delivery systems for the local treatment of resected glioblastoma.
Bastiancich C; Malfanti A; Préat V; Rahman R
Adv Drug Deliv Rev; 2021 Oct; 177():113951. PubMed ID: 34461201
[TBL] [Abstract] [Full Text] [Related]
20. Effective delivery of STING agonist using exosomes suppresses tumor growth and enhances antitumor immunity.
McAndrews KM; Che SPY; LeBleu VS; Kalluri R
J Biol Chem; 2021; 296():100523. PubMed ID: 33711340
[TBL] [Abstract] [Full Text] [Related]
[Next]
